Biomimetic Media Research Articles

Impact of prandial state on luminal and permeation-behavior of fosamprenavir oral suspension studied by in vitro tools: Solubility-, bioconversion- and permeation- studies in biomimetic media

Fosamprenavir is a prodrug designed to overcome the solubility challenge of the parent drug amprenavir, a protease inhibitor. For the marketed oral suspension (Telzir®) a clinically documented negative food effect has been reported.The present study aims to gain a better mechanistic understanding of the food effect by in vitro tests on solubility, bioconversion, permeability, and dynamic dissolution/bioconversion/permeation studies in a high throughput manner on a microtiter plate (Permeapad® Plate). In order to mimick luminal condition changes in connection with food, various modified versions of fasted and fed state simulated intestinal fluids (FaSSIF-V2) and (FeSSIF–V2) were used. The kinetics of enzymatic cleavage (simulated bioconversion) were studied in these media with a focus on molecularly dissolved drug concentrations using microdialysis. Dynamic dissolution/bioconversion/permeation experiments, indicated the following factors to contribute to reduced permeation in fed state: elevated inorganic phosphate concentrations, higher concentrations of bile salts and lipids and lower intestinal pH. The impact of these effects is difficult to capture in vivo due to their interconnection and large variability between individuals.This study revealed factors leading to an altered luminal behavior of Telzir® oral suspension in fed state, which may contribute to explain the observed reduced amprenavir absorption from the suspension. Especially the high throughput small-scale dissolution/bioconversion/permeation experiments on a microtiter plate were demonstrated an efficient and powerful tool for elucidating the food effects of phosphate-ester prodrug type drug products as far as their altered luminal behavior is concerned.

Upgrading of the general AMBER force field 2 for fluorinated alcohol biosolvents: A validation for water solutions and melittin solvation.

The standard GAFF2 force field parameterization has been refined for the fluorinated alcohols 2,2,2-trifluoroethanol (TFE), 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP), and 1,1,1,3,3,3-hexafluoropropan-2-one (HFA), which are commonly used to study proteins and peptides in biomimetic media. The structural and dynamic properties of both proteins and peptides are significantly influenced by the biomimetic environment created by the presence of these cosolvents in aqueous solutions. Quantum mechanical calculations on stable conformers were used to parameterize the atomic charges. Different systems, such as pure liquids, aqueous solutions, and systems formed by melittin protein and cosolvent/water solutions, have been used to validate the new models. The calculated macroscopic and structural properties are in agreement with experimental findings, supporting the validity of the newly proposed models.

Establishment of coverage-mass equation to quantify the corrosion inhomogeneity and examination of medium effects on iron corrosion.

Metal corrosion is important in the fields of biomedicine as well as construction and transportation etc. While most corrosion occurs inhomogeneously, there is so far no satisfactory parameter to characterize corrosion inhomogeneity. Herein, we employ the Poisson raindrop question to model the corrosion process and derive an equation to relate corrosion coverage and corrosion mass. The resultant equation is named coverage-mass equation, abbreviated as C-M equation. We also suggest corrosion mass at 50% coverage, termed as half-coverage mass M corro50%, as an inhomogeneity parameter to quantify corrosion inhomogeneity. The equation is confirmed and the half-coverage massM corro50% is justified in our experiments of iron corrosion in five aqueous media, normal saline, phosphate-buffered saline, Hank's solution, deionized water and artificial seawater, where the former three ones are biomimetic and very important in studies of biomedical materials. The half-coverage massM corro50% is proved to be more comprehensive and mathematically convergent than the traditional pitting factor. Iron corrosion is detected using visual observation, scanning electron microscopy with a build-in energy dispersive spectrometer, inductive coupled plasma emission spectrometry and electrochemical measurements. Both rates and inhomogeneity extents of iron corrosion are compared among the five aqueous media. The factors underlying the medium effects on corrosion rate and inhomogeneity are discussed and interpreted. Corrosion rates of iron in the five media differ about 7-fold, and half-coverage massvalues differ about 300000-fold. The fastest corrosion and the most significant inhomogeneity occur both in biomimetic media, but not the same one. The new equation (C-M equation) and the new quantity (half-coverage mass) are stimulating for dealing with a dynamic and stochastic process with global inhomogeneity including but not limited to metal corrosion. The findings are particularly meaningful for research and development of next-generation biodegradable materials.

Biopredictive capability assessment of two dissolution/permeation assays, µFLUX™ and PermeaLoop™, using supersaturating formulations of Posaconazole

The majority of new drug entities exhibits poor water solubility and therefore enabling formulations are often needed to ensure sufficient in vivo bioavailability upon oral administration. Several in vitro tools have been proposed for biopredictive screening of such drug formulations to facilitate formulation development. Among these, combined dissolution/permeation (D/P) assays have gained increasing interest in recent years, since they are presumed to better predict the absorption behavior as compared to single-compartment dissolution assays. Moreover, especially for supersaturating formulations, it has been demonstrated that the presence of an absorption sink better mimics the intraluminal supersaturation performance.The present study aimed to investigate the biopredictive abilities of two in vitro D/P setups to predict intestinal supersaturation and systemic absorption of supersaturable systems. Experiments were performed with a µFLUX™ and PermeaLoop™ apparatus, respectively, which differ primarily in their volume-to-area ratios between donor compartment and membrane as well as in the type of biomimetic barrier. A two-stage dissolution protocol was adopted to mimic the transit from acidic stomach to more neutral intestinal fluids using biomimetic media. Three formulations of the weakly basic compound Posaconazole (PCZ), namely an acidified and a neutral suspension and an amorphous solid dispersion (ASD) tablet, were tested.Under the present conditions, and for the specific set of formulations studied here, PermeaLoop™ showed a better biopredictive ability for intestinal supersaturation and systemic absorption for the three formulations than the µFLUX™ D/P setup. Interestingly, minor modifications of the two-stage D/P protocol in terms of medium transfer rates from simulated gastric fluid (SGF) to fasted state simulated intestinal fluid (FaSSIF) had a substantial impact particularly on the permeation of the crystalline PCZ suspension (“acidified suspension”). The ASD tablet was less sensitive to gradual medium changes than the crystalline PCZ suspensions. The current study confirms the usefulness of D/P assays for formulation ranking of weakly basic compounds and supersaturating formulations.

Microdialysis and nanofiltration allow to distinguish molecularly dissolved from colloid-associated drug concentrations during biomimetic dissolution testing of supersaturating formulations

Many new drug entities are poorly water-soluble and thus require solubility-enhancing formulations to ensure sufficient bioavailability. On the other hand, it is more and more accepted that not all “dissolved” states of a drug contribute equally to enhanced absorption, i.e. an increase in apparent solubility does not necessarily go in parallel with an increase in molecularly dissolved drug, the latter being regarded as the key driving force for absorption. Our study aimed to provide time-resolved information on the dissolution, supersaturation, and precipitation behavior of molecularly dissolved drug as released from an amorphous solid dispersion and a surfactant-containing crystalline suspension of Posaconazole (PCZ), a weakly basic and poorly water-soluble drug. Thereby, we aimed to gain a deeper mechanistic understanding of enabling formulation principles and possibly establish a dynamic biopharmaceutical assessment tool for molecularly dissolved drug released from enabling formulations.A two-staged dissolution test, with media transition from simulated gastric fluid (SGF) to fasted state simulated intestinal fluid (FaSSIF), was performed with three alternative sampling approaches in parallel: the classical bench centrifugation approach was used to assess total dissolved concentrations, while a nanofiltration method and a microdialysis setup were tested for their ability to discriminate molecularly and colloid-associated drug concentrations over time. For comparison, a single-stage dissolution setup was performed, where a marketed PCZ suspension was dispersed in biomimetic media with increasing amounts of solubilizing agents to understand their effect on the concentration of molecularly dissolved drug.It was demonstrated that the microdialysis setup allowed to follow the molecularly dissolved drug concentration in a time-resolved manner during the single-and two-stage dissolution tests with marginal delays. Interestingly, the PCZ concentrations measured by the nanofiltration approach differed from both, the molecularly dissolved (assessed by microdialysis) and apparently dissolved (assessed by centrifuge) PCZ concentrations, indicating that nanofiltration may allow to differentiate between different colloid-associated (apparently) dissolved drug species. Moreover, it was shown that the release of the molecularly dissolved drug from an amorphous solid dispersion did not correlate at all with the results obtained by the centrifugation method: While this conventional sampling revealed a classical spring and parachute concentration/time-profile with a high degree of (apparent) supersaturation, the concentration of molecularly dissolved drug (assessed by the microdialysis setup) indicated an initial short decline of PCZ concentration, followed by a prolonged (moderate) molecular supersaturation. This observation may give rise to a re-thinking of the current mechanistic understanding of how amorphous solid dispersions enhance oral bioavailability. In essence, the current study provides data which indicate a benefit of both the microdialysis sampling and nanofiltration approaches for the in vitro biopharmaceutical assessment of enabling drug formulations.

Dissolution/Permeation of Albendazole in the Presence of Cyclodextrin and Bile Salts: A Mechanistic In Vitro Study into Factors Governing Oral Bioavailability

We aimed to understand the impact of the interplay between bile salts and cyclodextrins on the dissolution-permeation of poorly soluble drug compounds with a moderate-strong binding constant to cyclodextrin. Phase diagrams were prepared on the chosen model compound albendazole in phosphate buffer, fasted state simulated intestinal fluid (FaSSIF), and a modified fed state simulated intestinal fluid (FeSSIFmod) with (2-hydroxypropyl)-beta-cyclodextrin (HP-β-CD) concentrations of up to 10 % (m/m). Then we investigated the dissolution/permeation interplay of albendazole dissolved/suspended in the different media through a biomimetic barrier on a 96-well in vitro model. The apparent solubility of albendazole was enhanced by HP-β-CD and FaSSIF/FeSSIFmod separately. However, when albendazole was dissolved in HP-β-CD and biomimetic media together, the solubility was significantly lower than the predicted additive solubility from the solubilizing effects. It is postulated that this is due to the sodium taurocholate from the biomimetic media displacing albendazole from the hydrophobic cavity of HP-β-CD. In the permeation experiments, the highest permeation was observed at cyclodextrin concentrations able to solubilize close to the total dose of albendazole without a major surplus of solubilization capacity. Furthermore, an over-proportional permeation enhancement was observed when both, cyclodextrin and biomimetic media were present. These results indicate that the interplay between bile salts and cyclodextrins can enhance the free (molecularly dissolved) fraction of drug in solution to a greater extent than could be obtained with one of the solubilizing components alone. In conclusion, at carefully selected cyclodextrin-concentrations in combination with biomimetic media, obviously, a transient supersaturation is induced, which is made responsible for the observed major permeation enhancement.

Solution structure of the anticancer p28 peptide in biomimetic medium.

The p28 peptide derived from Pseudomonas aeruginosa azurin shows an anticancer activity after binding to p53 protein and is currently in Phase I of clinical trials. We have studied its structure in water and in a biomimetic media and show that the peptide is unstructured in water but when studied in a biomimetic medium assumes a structure very similar to the one observed in azurin, suggesting a high propensity of this peptide to maintain this secondary structure. Analysis of p28 sequences from different bacterial species indicates conservation of the secondary structure despite amino acid replacement in different positions, suggesting that others, similar peptides could be tested for binding to p53.

High-resolution structural profile of hylaseptin-4: Aggregation, membrane topology and pH dependence of overall membrane binding process

Hylaseptin-4 (HSP-4, GIGDILKNLAKAAGKAALHAVGESL-NH2) is an antimicrobial peptide originally isolated from Hypsiboas punctatus tree frog. The peptide has been chemically synthetized for structural investigations by CD and NMR spectroscopies. CD experiments reveal the high helical content of HSP-4 in biomimetic media. Interestingly, the aggregation process seems to occur at high peptide concentrations either in aqueous solution or in presence of biomimetic membranes, indicating an increase in the propensity of the peptide for adopting a helical conformation. High-resolution NMR structures determined in presence of DPC-d38 micelles show a highly ordered α-helix from amino acid residues I2 to S24 and a smooth bend near G14. A large separation between hydrophobic and hydrophilic residues occurs up to the A16 residue, from which a shift in the amphipathicity is noticed. Oriented solid-state NMR spectroscopy show a roughly parallel orientation of the helical structure along the POPC lipid bilayer surface, with an insertion of the hydrophobic N-terminus into the bilayer core. Moreover, a noticeable pH dependence of the aggregation process in both aqueous and in biomimetic membrane environments is attributed to a single histidine residue (H19). The protonation degree of the imidazole side-chain might help in modulating the peptide-peptide or peptide-lipid interactions. Finally, molecular dynamics simulations confirm the orientation and preferential helical conformation and in addition, show that HSP-4 tends to self-aggregate in order to stabilize its active conformation in aqueous or phospholipid bilayer environments.

(Sub)micron particles forming in aqueous dispersions of amorphous solid dispersions of the poorly soluble drug ABT-199: A combined particle optical counting and field-flow fractionation study

The dispersive behavior of three different amorphous solid dispersion (ASD) formulations of the poorly soluble ABT-199 (Venetoclax) were studied in aqueous and biomimetic media and spontaneously forming supramolecular associates and particles analysed. To this end, the aqueous dispersions were fractionated into a submicron (colloidal) and micrometer-sized particle-fraction by bench-top centrifugation. The submicron fraction was characterized by Asymmetric Flow Field-Flow Fractionation in conjunction with Multi-angle Laser Light Scattering (AF4-MALLS), Dynamic Light Scattering (DLS) and zeta potential analysis. The micron particle fraction was characterized by Single Particle Optical Sensing (SPOS) and light microscopy. Furthermore, drug contents were monitored in terms of total dispersed drug and apparently dissolved drug in the submicron fraction. Despite the fact, that all three formulations showed decent dispersive behavior with almost the complete drug content rapidly dispersed, substantial differences were identified between two of the formulations and the third one: ABT-199/12 and ABT-199/20 showed pronounced precipitation of the drug in form of micrometer particles, a phenomenon described as glass liquid phase separation (GLPS) and only a marginal fraction of the drug was found in the submicron-fraction, i.e. associated with 3 to 4 different supramolecular assemblies (micelles), irrespective whether buffer or fasted state simulated intestinal fluid (FaSSIF) were used as dispersion media. In contrast, ABT-199/40 showed pronounced formation of a wide variety of supramolecular assemblies (micelles) along with substantial association of the drug with all of these, but reduced glass liquid phase separation.

Multivariate analysis of protolytic and tautomeric equilibria of Erythrosine B and its ester derivatives in ionic and non-ionic micelles

Erythrosine B (ERY) is a xanthene dye that has been widely used in recent years as a photoactive drug for Photodynamic Therapy. However, application of ERY and its derivatives as photosensitizer drugs depend not only on their singlet oxygen quantum yield, but also on their hydrophobicity, and photoactive protolytic and tautomeric species. In this work, the objective was to evaluate the acid-base equilibria of ERY and its derivatives: erythrosine methyl ester (ERYMET); erythrosine butyl ester (ERYBUT) and erythrosine decyl ester (ERYDEC), in biomimetic media (micelles of SDS and CTAB) as well as in some drug delivery systems of triblock copolymer Poloxamer (P-123 and F-127). All protolytic chemical equilibria were studied by employing chemometric multivariate analysis based on the Imbrie's Q-Mode Factor Analysis and k-Matrix methods. Tautomeric equilibria were evaluated taking into account of possible chemical structures and electronic spectroscopic approximations. Results from ester derivatives presenting only one protolytic equilibrium (at the phenolate group) and two possible tautomers, allow us to determine that protolytic equilibria follow the sequence pKaCOOH < pKaOH in SDS media for ERY by structure comparison. On the other hand, CTAB and polaxamers inverted the acidity of ERY protolytic groups (pKaOH < pKaCOOH) due to changes in the tautomeric equilibrium due to a lactone formation for the dyes neutral protolytic species inside the micelles. Chemometric approaches provided detailed analyses of protolytic/tautomeric equilibria of ERY. Through this, we achieved a deeper understanding of how ERY and its derivatives are affected by microenvironments in biomimetic and drug delivery systems.

In vitro characterization of ritonavir formulations and correlation to in vivo performance in dogs

Ritonavir (RTV) is a weakly basic drug with a pH-dependent solubility. In vitro characterization of dissolution and supersaturation behaviors of three PEG-8000 based amorphous solid dispersions (ASD) and a physical blend (PB) with crystalline drug were performed in the biomimetic media (e.g., FaSSGF, FaSSIF, FaSSIF-V2). A two-stage dissolution test and a biphasic dissolution-partition test at the small scale (referred as to biphasic test) were employed with intention to examine the in vitro and in vivo relationship (IVIVR) with retrospective PK data in dog model.The two-stage dissolution test revealed a high degree of supersaturation of RTV from these ASDs accompanied by the occurrence of liquid–liquid phase separation (LLPS) in the biomimetic media. A rapid decrease of apparent RTV concentrations of these ASDs was associated with significant precipitation upon the pH shift of the dissolution medium, revealing the important role of “the gastric stage”. In comparison, the biphasic test revealed a lower degree of supersaturation of RTV that is attributed to removal of RTV through partition into octanol, acting as “the absorption compartment”. These two dissolution tests provide characterization of the supersaturation state with a complex, dynamic interplay among dissolution, precipitation and partition processes. Results of both in vitro dissolution tests are in good agreement with in vivo results in dogs. In addition, three commercial generic RTV drug products were examined by the biphasic test. Agreement was also obtained between the RTV concentrations in octanol at 3 h from these generic drug products and their corresponding relative bioavailability in dogs.

A novel injectable hydrogel system based on polyampholyte microgels

The present study reports dual tetanus and diphtheria toxoids loaded stable chitosan–glucomannan nanoassemblies (sCh–GM-NAs) formulated using tandem ionic gelation technique for oral mucosal immunization. The stable, lyophilized sCh–GM-NAs exhibited ~152 nm particle size and ~85% EE of both the toxoids. The lyophilized sCh–GM-NAs displayed excellent stability in biomimetic media and preserved chemical, conformation and biological stability of encapsulated toxoids. The higher intracellular APCs uptake of sCh–GM-NAs was concentration and time dependent which may be attributed to the receptor mediated endocytosis via mannose and glucose receptor. The higher Caco-2 uptake of sCh–GM-NAs was further confirmed by ex vivo intestinal uptake studies. The in vivo evaluation revealed that sCh–GM-NAs posed significantly (p < 0.001) higher humoral, mucosal and cellular immune response than other counterparts by eliciting complete protective levels of anti-TT and anti-DT (~0.1 IU/mL) antibodies. Importantly, commercial ‘Dual antigen’ vaccine administered through oral or intramuscular route was unable to elicit all type of immune response. Conclusively, sCh–GM-NAs could be considered as promising vaccine adjuvant for oral mucosal immunization.

Design and fabrication of TPP cross-linked chitosan hydrogels with tunable stimuli-responsive properties and their application on drug delivery

The present study reports dual tetanus and diphtheria toxoids loaded stable chitosan–glucomannan nanoassemblies (sCh–GM-NAs) formulated using tandem ionic gelation technique for oral mucosal immunization. The stable, lyophilized sCh–GM-NAs exhibited ~152 nm particle size and ~85% EE of both the toxoids. The lyophilized sCh–GM-NAs displayed excellent stability in biomimetic media and preserved chemical, conformation and biological stability of encapsulated toxoids. The higher intracellular APCs uptake of sCh–GM-NAs was concentration and time dependent which may be attributed to the receptor mediated endocytosis via mannose and glucose receptor. The higher Caco-2 uptake of sCh–GM-NAs was further confirmed by ex vivo intestinal uptake studies. The in vivo evaluation revealed that sCh–GM-NAs posed significantly (p < 0.001) higher humoral, mucosal and cellular immune response than other counterparts by eliciting complete protective levels of anti-TT and anti-DT (~0.1 IU/mL) antibodies. Importantly, commercial ‘Dual antigen’ vaccine administered through oral or intramuscular route was unable to elicit all type of immune response. Conclusively, sCh–GM-NAs could be considered as promising vaccine adjuvant for oral mucosal immunization.

Degradation of magnetite nanoparticles in biomimetic media

Magnetic nanoparticles (NPs) of magnetite Fe3O4 obtained by coprecipitation (COP), thermal decomposition (DT), and commercial sample (CM) have been degraded in similar conditions to physiological medium at pH 4.7 and in simulated body fluid (SBF) at pH 7.4. The formation of the nanoparticles was confirmed by FTIR spectroscopy, X-ray diffraction (XRD), scanning electron microscopy (SEM), and transmission electron microscopy (TEM). In view of medical and environmental applications, the stability of the particles was measured with dynamic light scattering. The degradation processes were followed with atomic absorption spectroscopy (EAA) and TEM. Magnetic measurements were carried out using vibrating sample magnetometry (VSM). Our results revealed that the structural and magnetic properties of the remaining nanoparticles after the degradation process were significantly different to those of the initial suspension. The degradation kinetics is affected by the pH, the coating, and the average particle size of the nanoparticles.

Dynamic dissolution-/permeation-testing of nano- and microparticle formulations of fenofibrate

The aim of the current study was to evaluate a dynamic dissolution-/permeation-system for prediction of gastrointestinal and absorption-behavior of two commercial fenofibrate formulations. To this end, both dissolution and barrier-flux were followed simultaneously for fenofibrate powder, a microparticle formulation (Lipidil® 200mg) and a nanoparticle formulation (LIPIDIL 145 ONE®) using a pair of side-by side diffusion cells separated by a cellulose hydrate membrane. Under such dynamic conditions, transient supersaturation arising from the nanoparticle formulation could be demonstrated for the first time.Furthermore, the dissolution-/permeation-system introduced here allowed for in-depth mechanistic insights: Biomimetic media, despite enhancing the apparent solubility of fenofibrate via micellar solubilization, did not increase permeation rate, irrespective whether the micro-/ or nanoparticle-formulation was tested. Nondissolved nano-/microparticles served as a reservoir helping to maintain high levels of molecularly dissolved drug, which in turn caused high and constant permeation rates. The micelle-bound drug may also serve as a drug-reservoir, yet of subordinate importance as long as there are nano-/microparticles present.Despite the limitations of the current experimental set-up, combined dissolution-/permeation-testing appears a valuable new tool to promote mechanistic understanding during formulation development. Last but not least, the in vitro dissolution and permeation behavior revealed here was in good qualitative agreement with human duodenal and plasma values reported in literature for the same formulations.

Permeapad™ for investigation of passive drug permeability: The effect of surfactants, co-solvents and simulated intestinal fluids (FaSSIF and FeSSIF)

The aim of the present work was to investigate the potential of the new and innovative artificial barrier, Permeapad™, when exposed to surfactants and co-solvents, often employed for poorly water soluble compounds. The barrier was in addition also exposed to fasted and fed state simulated intestinal fluids versions 1 and 2 (FaSSIF and FeSSIF), all of which the Permeapad™ barrier was compatible with based upon relative comparison of the permeability of the hydrophilic marker calcein in phosphate buffer. The new barrier therefore holds a huge potential due to its functional stability and robustness. It can be used as a standard tool to investigate permeability of drugs in the presence of different surfactants and co-solvents, from DMSO stock solutions at even high concentrations and for the evaluation of permeability in the presence of biomimetic media (BMM).11Biomimetic media=BMM.

Divalent toxoids loaded stable chitosan–glucomannan nanoassemblies for efficient systemic, mucosal and cellular immunostimulatory response following oral administration

The present study reports dual tetanus and diphtheria toxoids loaded stable chitosan–glucomannan nanoassemblies (sCh–GM-NAs) formulated using tandem ionic gelation technique for oral mucosal immunization. The stable, lyophilized sCh–GM-NAs exhibited ~152nm particle size and ~85% EE of both the toxoids. The lyophilized sCh–GM-NAs displayed excellent stability in biomimetic media and preserved chemical, conformation and biological stability of encapsulated toxoids. The higher intracellular APCs uptake of sCh–GM-NAs was concentration and time dependent which may be attributed to the receptor mediated endocytosis via mannose and glucose receptor. The higher Caco-2 uptake of sCh–GM-NAs was further confirmed by ex vivo intestinal uptake studies. The in vivo evaluation revealed that sCh–GM-NAs posed significantly (p<0.001) higher humoral, mucosal and cellular immune response than other counterparts by eliciting complete protective levels of anti-TT and anti-DT (~0.1IU/mL) antibodies. Importantly, commercial ‘Dual antigen’ vaccine administered through oral or intramuscular route was unable to elicit all type of immune response. Conclusively, sCh–GM-NAs could be considered as promising vaccine adjuvant for oral mucosal immunization.

Real-time analysis of composite magnetic nanoparticle disassembly in vascular cells and biomimetic media

The fate of nanoparticle (NP) formulations in the multifaceted biological environment is a key determinant of their biocompatibility and therapeutic performance. An understanding of the degradation patterns of different types of clinically used and experimental NP formulations is currently incomplete, posing an unmet need for novel analytical tools providing unbiased quantitative measurements of NP disassembly directly in the medium of interest and in conditions relevant to specific therapeutic/diagnostic applications. In the present study, this challenge was addressed with an approach enabling real-time in situ monitoring of the integrity status of NPs in cells and biomimetic media using Förster resonance energy transfer (FRET). Disassembly of polylactide-based magnetic NPs (MNPs) was investigated in a range of model biomimetic media and in cultured vascular cells using an experimentally established quantitative correlation between particle integrity and FRET efficiency controlled through adjustments in the spectral overlap between two custom-synthesized polylactide-fluorophore (boron dipyrromethene) conjugates incorporated in MNPs. The results suggest particle disassembly governed by diffusion-reaction processes with kinetics strongly dependent on conditions promoting release of oligomeric fragments from the particle matrix. Thus, incubation in gels simulating the extracellular environment and in protein-rich serum resulted in notably lower and higher MNP decomposition rates, respectively, compared with nonviscous liquid buffers. The diffusion-reaction mechanism also is consistent with a significant cell growth-dependent acceleration of MNP processing in dividing vs. contact-inhibited vascular cells. The FRET-based analytical strategy and experimental results reported herein may facilitate the development and inform optimization of biodegradable nanocarriers for cell and drug delivery applications.

Two-channel dansyl/tryptophan emitters with a cholic acid bridge as reporters for local hydrophobicity within supramolecular systems based on bile salts.

The aim of the present work is to develop two-channel emitters to probe local hydrophobicity by means of fluorescence quenching within different biomimetic supramolecular environments. To achieve this goal, the dansyl (Dns) and tryptophan (Trp) fluorophores have been covalently attached to cholic acid (CA) in order to ensure simultaneous incorporation of the two emitting units into the same compartment. In principle, the two fluorophores of the synthesized Dns-CA-Trp probes could either exhibit an orthogonal behavior or display excited state interactions. The fluorescence spectra of 3β-Dns-CA-Trp showed a residual Trp emission band at ca. 350 nm and an enhanced Dns maximum in the 500-550 nm region. This reveals a partial intramolecular energy transfer, which is consistent with the Dns and Trp singlet energies. Thus, the two photoactive units are not orthogonal; nevertheless, 3β-Dns-CA-Trp seems appropriate as a two-channel reporter for the supramolecular systems of interest. Fluorescence quenching of 3β-Dns-CA-Trp by iodide (which remains essentially in bulk water) was examined within sodium cholate, sodium taurocholate, sodium deoxycholate and mixed micelles. Interestingly, a decrease in the emission intensity of the two bands was observed with increasing iodide concentrations. The most remarkable effect was observed for mixed micelles, where the quenching rate constants were one order of magnitude lower than in solution. As anticipated, the quenching efficiency by iodide decreased with increasing hydrophobicity of the microenvironment, a trend that can be correlated with the relative accessibility of the probe to the ionic quencher.

Lipid oxidation induces structural changes in biomimetic membranes.

Oxidation can intimately influence and structurally compromise the levels of biological self-assembly embodied by intracellular and plasma membranes. Lipid peroxidation, a natural metabolic outcome of life with oxygen under light, is also a salient oxidation reaction in photomedicine treatments. However, the effect of peroxidation on the fate of lipid membranes remains elusive. Here we use a new photosensitizer that anchors and disperses in the membrane to achieve spatial control of the oxidizing species. We find, surprisingly, that the integrity of unsaturated unilamellar vesicles is preserved even for fully oxidized membranes. Membrane survival allows for the quantification of the transformations of the peroxidized bilayers, providing key physical and chemical information to understand the effect of lipid oxidation on protein insertion and on other mechanisms of cell function. We anticipate that spatially controlled oxidation will emerge as a new powerful strategy for tuning and evaluating lipid membranes in biomimetic media under oxidative stress.